AMAG Pharma (AMAG) Posts Q2 Loss of $0.40
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Nasdaq eyes lower open after midterms-fueled surge as chip, data center stocks fall
- Massive market rotation raises question: Is the sell-AI trade here to stay?
- Goldman sees major AI and data center policy implications from ‘blue tsunami’
- Nvidia chips stockpile in Hong Kong awaits China import approval - report
- Goldman says this FX trade is the best hedge for the AI drawdown
Tweet
Share
E-mailGet Alerts AMAG Hot Sheet
Price: $13.75 --0%
Financial Fact:
Product sales, net: 115.78M
Today's EPS Names:
ROX, KEEL, SENEA, More
Financial Fact:
Product sales, net: 115.78M
Today's EPS Names:
ROX, KEEL, SENEA, More
Join SI Premium – FREE
AMAG Pharma (NASDAQ: AMAG) reported Q2 EPS of ($0.40), which may note compare to the analyst estimate of $1.34. Revenue for the quarter came in at $159.7 million versus the consensus estimate of $158.59 million.
For earnings history and earnings-related data on AMAG Pharma (AMAG) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Parker-Hannifin (PH) Tops Q1 EPS by 69c ; Offers Guidance
- MDU Resources Group (MDU) Misses Q3 EPS by 2c ; Offers Guidance
- Intensity Therapeutics, Inc. (INTS) Misses Q3 EPS by 13c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
